Mucin model for group B type III streptococcal infection in mice

Area of Science:

• Microbiology
• Immunology
• Infectious Diseases

Background:

• Streptococcus agalactiae (group B Streptococcus) is a significant human pathogen.
• Murine models are crucial for studying bacterial virulence and host resistance.
• Gastric mucin has been observed to enhance bacterial virulence in some models.

Purpose of the Study:

• To investigate the role of iron in mucin-mediated enhancement of Streptococcus agalactiae virulence.
• To determine if iron chelation or supplementation affects the outcome of experimental streptococcal infections.

Main Methods:

• Experimental murine infection model using intraperitoneal injection of Streptococcus agalactiae (group B, type III) in ICR Swiss mice.
• Assessment of virulence enhancement by measuring increased mortality.
• Testing the effect of mucin treated with Desferal (iron chelator) on virulence.
• Evaluating iron-dextran as a substitute for mucin in enhancing virulence.

Main Results:

• Intraperitoneal injection of Streptococcus agalactiae in hog gastric mucin significantly increased mortality in outbred ICR Swiss mice.
• Inbred C57BL6 mice showed resistance to the mucin-bacterial combination.
• Mucin treated to chelate iron retained its capacity to enhance Streptococcus agalactiae virulence.
• Iron-dextran failed to enhance the virulence of Streptococcus agalactiae.

Conclusions:

• Iron is not the resistance-lowering factor in the group B, type III Streptococcus agalactiae-mucin model.
• The mechanism by which gastric mucin enhances Streptococcus agalactiae virulence in susceptible mice requires further investigation.
• Host genetic factors (e.g., inbred C57BL6 mice) play a role in resistance to this infection model.